Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Steris to add contract sterilization services with $142 mil. Isomedix acquisition.

This article was originally published in The Gray Sheet

Executive Summary

STERIS WOULD ADD CONTRACT STERILIZATION SERVICES WITH $142 MIL. ISOMEDIX BUY announced Aug. 12. The firms have entered a definitive merger agreement that would result in Steris' adding the complementary business of contract sterilization to its line of infection prevention, contamination prevention, and surgical support systems and services. Isomedix provides gamma radiation and ethylene oxide contract sterilization services to manufacturers of pre-packaged medical devices and consumer products.

You may also be interested in...

Steris' Isotron Acquisition Adds European Contract Sterilization Services

The purchase of contract sterilization and related services firm Isotron gives Steris a foothold in the European market on which to further expand throughout the continent. Announced July 20, the cash deal is valued at $110 mil.

Podcast: Diversity, Equity, and Inclusion Measures Continue to Evolve in the Clinical Space

Listen to expert perspectives from Tracey Parker, Vice President, Biometrics, Advanced Clinical and Rebecca Starkie, Senior Global Patient Engagement Director, Advanced Clinical on the recent history of DEI in clinical trials and the barriers to patient participation. Examine the key drivers that have influenced the development of diversity, equity, and inclusion programs for clinical trials.

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts